<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xml:lang="en" article-type="editorial" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Endocrinol (Lausanne)</journal-id><journal-id journal-id-type="pmc-domain-id">1753</journal-id><journal-id journal-id-type="pmc-domain">frontendo</journal-id><journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id><journal-title-group><journal-title>Frontiers in Endocrinology</journal-title></journal-title-group><issn pub-type="epub">1664-2392</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11560769</article-id><article-id pub-id-type="pmcid-ver">PMC11560769.1</article-id><article-id pub-id-type="pmcaid">11560769</article-id><article-id pub-id-type="pmcaiid">11560769</article-id><article-id pub-id-type="pmid">39544237</article-id><article-id pub-id-type="doi">10.3389/fendo.2024.1500755</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Endocrinology</subject><subj-group><subject>Editorial</subject></subj-group></subj-group></article-categories><title-group><article-title>Editorial: Insights in Cushing’s syndrome and disease, volume II</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Langlois</surname><given-names initials="F">Fabienne</given-names></name><xref rid="fn001" ref-type="author-notes">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/540572"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1">
<institution>Department of Medicine, Division of Endocrinology, Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie, Centre Hospitalier Universitaire de Sherbrooke</institution>, <addr-line>Sherbrooke, QC</addr-line>, <country>Canada</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited and Reviewed by: Nienke Biermasz, Leiden University, Netherlands</p></fn><corresp id="fn001">*Correspondence: Fabienne Langlois, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:fabienne.langlois@usherbrooke.ca">fabienne.langlois@usherbrooke.ca</email>
</corresp></author-notes><pub-date pub-type="epub"><day>31</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">454534</issue-id><elocation-id>1500755</elocation-id><history><date date-type="received"><day>23</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>14</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>14</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-15 09:25:16.850"><day>15</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright © 2024 Langlois</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Langlois</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fendo-15-1500755.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary-article" xml:lang="en" ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/55778/insights-in-cushings-syndrome-and-disease-volume-ii/magazine"/><kwd-group><kwd>Cushing syndrome</kwd><kwd>Cushing disease (CD)</kwd><kwd>cortisol</kwd><kwd>hypercortisolism</kwd><kwd>adrenal Cushing syndrome</kwd><kwd>ectopic Cushing syndrome</kwd></kwd-group><counts><fig-count count="0"/><table-count count="0"/><equation-count count="0"/><ref-count count="3"/><page-count count="2"/><word-count count="502"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>section-in-acceptance</meta-name><meta-value>Pituitary Endocrinology</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Endogenous Cushing’s syndrome results in significant multisystemic morbidity and elevated mortality if left untreated (<xref rid="B1" ref-type="bibr">1</xref>). The manifestations of this condition impact multiple organs and systems, and the clinical presentation of the disease varies widely among individuals. A high index of clinical suspicion is essential for accurate diagnosis, which necessitates multiple sequential tests, each requiring careful interpretation (<xref rid="B2" ref-type="bibr">2</xref>). The complexity of diagnosing and managing this condition demands individualized approaches and presents ongoing challenges for endocrinologists (<xref rid="B3" ref-type="bibr">3</xref>).</p></sec><sec id="s2"><title>Aims and objectives</title><p>This Research Topic encompasses original studies addressing critical clinical questions aimed at improving the diagnosis and treatment of patients with Cushing’s syndrome. The objective is to gather novel insights into the disease to assist clinicians in patient management and to inform research initiatives.</p></sec><sec id="s3"><title>Overview of the contributions</title><p>The study by <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2024.1302667" ext-link-type="uri">Pekul et al.</ext-link> emphasized the relevance of USP and TP53 mutations in pituitary tumors for prognostic guidance by comparing corticotroph tumors causing Cushing’s disease (CD) with their silent counterparts.</p><p>A meta-analysis by <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2024.1332120" ext-link-type="uri">Giampetro et al.</ext-link> evaluated the use of desmopressin for diagnostic purposes, a review that is particularly relevant given the limited availability of CRH in many countries. The article discussed the strengths and limitations of interpreting the 10mcg desmopressin test in differentiating between ACTH-dependent Cushing’s syndrome and non-neoplastic hypercortisolism. Additionally, a retrospective cohort study presented by <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2023.1224001" ext-link-type="uri">Skrebsky De Almeida et al.</ext-link> investigated the role of desmopressin during Bilateral Inferior Petrosal Sinus Sampling (BIPSS), presenting sensitivity and specificity values of the central-to-peripheral ratio before and after stimulation.</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2023.1230447" ext-link-type="uri">Wright et al.</ext-link> provided a review of emerging diagnostic methods, including advanced functional imaging and measurement of hair cortisol and cortisone, addressing the limitations of current tests while highlighting the advantages of novel approaches with the potential to transform the investigation of the condition.</p><p>The impact of hypercortisolism on the gut microbiota was explored in a case-control study by <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2023.1074757" ext-link-type="uri">Valassi et al.</ext-link> that offered insights into the ongoing cardiometabolic consequences of Cushing’s syndrome.</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2023.1270455" ext-link-type="uri">Jurek et al. </ext-link>conducted a prospective study of the hemodynamic profile of newly diagnosed CD patients, analyzing results by sex.</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2023.1165681" ext-link-type="uri">Feelders et al.</ext-link> shared the results of the extension of a multicenter Phase II study in which patients were initially treated with pasireotide which was subsequently combined with cabergoline if cortisol levels remained elevated. The study demonstrated that this combination of pituitary-targeted therapies can yield sustained long-term efficacy in selected patients.</p><p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://doi.org/10.3389/fendo.2024.1353543" ext-link-type="uri">Zhang and Ioachimescu</ext-link> discussed the post-surgical recovery phase in a mini review, highlighting the need for clinicians to anticipate the glucocorticoid withdrawal syndrome and adequately prepare their patients for this challenging phase, during which symptoms may initially worsen before improving. This review presents novel data to enhance understanding of the condition and suggests management strategies.</p></sec><sec id="s4"><title>Call to action</title><p>This Research Topic highlights several key areas of ongoing research aimed at advancing our understanding of Cushing’s syndrome. It underscores the importance of collaborative efforts to improve the health and quality of life of patients affected by this condition.</p></sec></body><back><sec sec-type="author-contributions" id="s5"><title>Author contributions</title><p>FL: Writing – original draft, Writing – review &amp; editing.</p></sec><sec sec-type="COI-statement" id="s6"><title>Conflict of interest</title><p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p><p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p></sec><sec sec-type="disclaimer" id="s7"><title>Publisher’s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gadelha</surname><given-names>M</given-names></name><name name-style="western"><surname>Gatto</surname><given-names>F</given-names></name><name name-style="western"><surname>Wildemberg</surname><given-names>LE</given-names></name><name name-style="western"><surname>Fleseriu</surname><given-names>M</given-names></name></person-group>. <article-title>Cushing’s syndrome</article-title>. <source>Lancet</source>. (<year>2023</year>) <volume>402</volume>:<page-range>2237–52</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(23)01961-X</pub-id>
<pub-id pub-id-type="pmid">37984386</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fleseriu</surname><given-names>M</given-names></name><name name-style="western"><surname>Auchus</surname><given-names>R</given-names></name><name name-style="western"><surname>Bancos</surname><given-names>I</given-names></name><name name-style="western"><surname>Ben-Shlomo</surname><given-names>A</given-names></name><name name-style="western"><surname>Bertherat</surname><given-names>J</given-names></name><name name-style="western"><surname>Biermasz</surname><given-names>NR</given-names></name><etal/></person-group>. <article-title>Consensus on diagnosis and management of Cushing’s disease: a guideline update</article-title>. <source>Lancet Diabetes Endocrinol</source>. (<year>2021</year>) <volume>9</volume>:<page-range>847–75</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S2213-8587(21)00235-7</pub-id>
<pub-id pub-id-type="pmcid">PMC8743006</pub-id><pub-id pub-id-type="pmid">34687601</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fleseriu</surname><given-names>M</given-names></name><name name-style="western"><surname>Varlamov</surname><given-names>EV</given-names></name><name name-style="western"><surname>Hinojosa-Amaya</surname><given-names>JM</given-names></name><name name-style="western"><surname>Langlois</surname><given-names>F</given-names></name><name name-style="western"><surname>Melmed</surname><given-names>S</given-names></name></person-group>. <article-title>An individualized approach to the management of Cushing disease</article-title>. <source>Nat Rev Endocrinol</source>. (<year>2023</year>) <volume>19</volume>:<page-range>581–99</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41574-023-00868-7</pub-id>
<pub-id pub-id-type="pmid">37537306</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>